Screening
Reference 1 HTS Systems Reliability Trends 2010 Report, published by HTStec Limited, Cambridge, UK, September 2010.
closer, to greater understand the underlying causes of poor reliability, so improvements can be driven by observation and the necessary confidence gained to promote the wider adoption of 24-7 operation. For example, detailed analysis of the individual survey responses revealed one lab that gave its system relatively high marks for reliability and had little downtime, but at the same time com- mented that the software doesn’t work very well and needs to be entirely rewritten.
What this article also highlights is the need for drug discovery companies to give greater recogni- tion of the significant contribution HTS systems make. In addition, those groups tasked with oper- ating such systems need to take greater ownership of that role, champion their impact more widely on the drug discovery process and embrace the chal- lenge of facilitating the widest possible operation of their systems. Downtime is not only about the immediate rectification of system malfunctions or errors, it is the realisation that failure to maximise the use of such strategic assets is costing the indus- try dearly.
DDW
Dr John Comley is Managing Director of HTStec Limited, an independent market research consul- tancy whose focus is on assisting clients delivering novel enabling platform technologies (liquid han- dling, laboratory automation, detection instrumen- tation and assay reagent technologies) to drug dis- covery and the life sciences. Since its formation seven years ago, HTStec has published more than 50 market reports on enabling technologies and Dr Comley has authored more than 30 review articles in Drug Discovery World. Please contact
info@htstec.com for more information about HTStec reports.
Biocius Life Sciences BioTek Instruments, Inc BMG Labtech Gmbh
Cambridge Healthtech Institute Cellular Dynamics International, Inc DiscoveRx Corporation Eyeforpharma Fluofarma
ForteBio, Inc
43 75 72 53 30 29 51 8
46
ADVERTISEMENT INDEX 57
HTStec Ltd Hudson Robotics, Inc ID Business Solutions Ltd
Life Technologies Corporation Mirus Bio LLC
Molecular Devices, Inc
PerkinElmer Life & Analytical Sciences Qiagen Gmbh
Roche Applied Science
69,71 54 33 23 6
40 18 45
Seahorse Bioscience, Inc Select Biosciences Ltd
Society for Laboratory Automation & Screening
Tecan Schweiz AG
Thermo Fisher Scientific TTP LabTech Ltd
13 IBC 77
IFC-3 OBC 4
78
Drug Discovery World Winter 2010/11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80